About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Asthma in the spotlight as Upstream Bio starts trial and UK universities propose new long-term treatment

Relmada Therapeutics gets Fast Track designation for major depressive disorder treatment

Study says gene editing with CRISPR/Cas9 can lead to cell toxicity and genome instability

Pfizer and Valneva to start phase 3 Lyme disease vaccine study

Dallas College gets $8.8M grant to grow biotech workforce in North Texas

Epigenic Therapeutics raises $20M for gene editing technology

ADVERTISEMENT

Beyond Biotech podcast 8: Biotech Growth Trust, Deep Science Ventures, Endogena Therapeutics, eureKARE

Immunis closes $10M financing round

Sanofi and Innovent Biologics to collaborate on oncology medicines and boost China presence

Novavax starts COVID-19 vaccine trial for children aged six months to 11 years

Gilead Sciences set to acquire MiroBio for $405M

RoslinCT and Lykan Bioscience combine to create cell therapy CDMO

ADVERTISEMENT